Search the Newsreel

Icu Medical stock hits 52-week high at 182.35 USD

ICU Medical (ICUI) stock reached a new 52-week high of $182.35, driven by positive market sentiment and strong financial performance. The company exceeded Q2 earnings and revenue expectations and raised its full-year EPS guidance, further boosted by an analyst upgrade to a $200 price …

ICU Medical Inc (ICUI) (Q2 2026) Earnings Call Highlights: Strong Organic Growth and Raised ...

This article first appeared on GuruFocus. Release Date: August 06, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points ICU Medical Inc (NASDAQ:ICUI) delivered strong Q2 2026 results with total company organic revenue growth …

ICU Medical Q2 2026 Earnings: Organic Growth Supports Higher Guidance

ICU Medical (Nasdaq: ICUI) reported Q2 2026 revenue of $551.7 million, a 1% increase year-over-year, with organic revenue up 6% excluding divestitures and currency effects. The company saw strong performance in Infusion Systems and Consumables, while Vital Care continued to decline. Consequently, ICU Medical …

ICU Medical Announces Second Quarter 2026 Results and Updates its Fiscal Year 2026 Guidance

ICU Medical, Inc. announced its financial results for the second quarter of 2026, reporting GAAP revenue growth of 1% year-over-year, and a non-GAAP organic revenue increase of 6% excluding the impact of a divestiture and foreign currency. The company also updated its fiscal year …

ICU Medical (ICUI) Reports Q2 Earnings: What Key Metrics Have to Say

ICU Medical (ICUI) reported its Q2 2026 earnings, with revenues of $547.88 million, an increase of 0.8% year-over-year, and EPS of $2.37, up from $2.10 in the prior year. Both revenue and EPS surpassed Zacks Consensus Estimates by 2.33% and 24.08% respectively. Key metrics …

ICU Medical (ICUI) Tops Q2 Earnings and Revenue Estimates

ICU MEDICAL ($ICUI) Releases Q2 2026 Earnings, Stock Rises

Earnings Flash (ICUI) ICU Medical, Inc. Reports Q2 Revenue $551.7M, vs. FactSet Est of $533.4M

ICU Medical, Inc. (ICUI) announced Q2 2026 revenue of $551.7 million, surpassing the FactSet estimate of $533.4 million. The company also reported Q2 adjusted EPS of $2.37 per share, exceeding the FactSet estimate of $1.91, and has lifted its 2026 guidance. This financial performance …

ICU Medical (NASDAQ:ICUI) Reports Strong Q2 CY2026

ICU Medical (NASDAQ:ICUI) Reports Strong Q2 CY2026 Medical device company ICU Medical (NASDAQ:ICUI) reported Q2 CY2026 results beating Wall Street's revenue expectations , with sales up 1.5% year on year to $551.7 million. Its non-GAAP profit of $2.37 per share was 23.8% above analysts' …

ICU Medical: Q2 Earnings Snapshot

ICU Medical (NASDAQ: ICUI) posts $551.7M Q2 revenue and $49.2M H1 net income

ICUI Looks 38.3% Overvalued on GF Value™ as Q2 Revenue Beats Est

ICU Medical raises full-year 2026 earnings outlook in Q2 report

A Look at ICU Medical Inc (ICUI) After 3.3% Decline -- GF Value $120.31 vs Price $166.40

ICU Medical Inc (ICUI) experienced a 3.3% share decline, bringing its price to $166.40, while its GF Value is estimated at $120.31, suggesting the stock is 38.3% overvalued. Despite a strong GF Score of 80/100, indicating solid fundamentals, both its financial strength and valuation …

ICU Medical (ICUI) Reports Q2: Everything You Need To Know Ahead Of Earnings

ICU Medical (ICUI) is scheduled to report its Q2 earnings this Thursday after market close. The market anticipates a 2% year-on-year revenue decline, an improvement from last year's 6.4% decrease. The company has a history of surpassing Wall Street expectations and its stock is …

ICU Medical, Inc. (ICUI) Stock Analysis: Assessing Growth Potential And Analyst Consensus

ICU Medical, Inc. (ICUI), a key player in medical instruments with a $4.32 billion market cap, shows a positive stock recovery over the past year, trading above moving averages. Despite a 12.30% revenue contraction, the company boasts a robust $387 million free cash flow …

ICU Medical (ICUI) Could Be 2% Undervalued As Recall Questions Meet A Full P E

ICU Medical Inc (ICUI) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis of ICU Medical Inc (ICUI), noting its current valuation score of 8.38, ranking 90th in the Healthcare Equipment & Supplies industry. It highlights the company's P/E ratio of 89.70 and mentions that relevant data for P/B, P/S, and …

ICU Medical, Inc. Revenue Breakdown – FWB:IC7

ICU Medical, Inc. (FWB:IC7) generated a total revenue of ‪1.88 billion EUR last year. The Consumables segment was the top performer, contributing ‪944.33 million EUR, while the United States was the largest regional contributor with ‪1.15 billion EUR in revenue. This article details the …

(ICUI) and the Role of Price-Sensitive Allocations

This article provides an AI-driven analysis of Icu Medical Inc. (NASDAQ: ICUI), highlighting strong near and mid-term sentiment and the absence of overhead resistance, suggesting upside potential. It presents three institutional trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—along with multi-timeframe signal analysis, including …

ICU Medical Number of Employees 2026 | Employee Count & Headcount Data

As of March 2026, ICU Medical, Inc. (ICUI) has approximately 12,991 employees worldwide, marking a 0.1% growth since 2023 but a 0.5% decline year-over-year. The company is actively hiring with 174 job postings in 2026, although new postings have cooled. The workforce is concentrated …

ICUI|ICU Medical Inc|Price:169.747|Chg%:+3.217

This article provides a comprehensive stock analysis of ICU Medical Inc (ICUI), highlighting its strong fundamentals, high growth potential, and "fairly valued" status. It notes high institutional ownership and analyst ratings predominantly as "Buy." The analysis covers its product portfolio and financial performance, including …

ICU Medical Inc (ICUI) Institutional Confidence

ICU Medical Inc (ICUI) has an institutional shareholding score of 10.00, placing it first among 199 companies in the Healthcare Equipment & Supplies industry. The institutional shareholding proportion is 114.41%, a 3.95% decrease quarter-over-quarter. ETHSX is the largest institutional shareholder with 168.43K shares, representing …

ICU Medical Inc (ICUI) Risk Assessment: Volatility, Financial Risk & Investment Risk

This article provides a risk assessment for ICU Medical Inc (ICUI), noting its current score of 7.52, ranking 36th in the Healthcare Equipment & Supplies industry. The company's beta of 0.78 suggests it tends to underperform in bull markets but offers greater stability during …

2 Momentum Stocks on Our Watchlist and 1 We Ignore

2 Momentum Stocks on Our Watchlist and 1 We Ignore The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorable industry trends, or improved financial performance. While momentum can be …

ICU Medical Inc - Detailed Introduction, Company Background, Business Scope, Financial Data, and Market Performance | TradingKey

ICU Medical Inc. (ICUI) develops, manufactures, and sells medical products for infusion therapy, vascular access, and vital care. The company's product portfolio includes various IV pumps, IV sets, connectors, catheters, and oncology products. The article also provides detailed company information, executive leadership, and institutional …

ICU Medical Inc (ICUI) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of ICU Medical Inc (ICUI) focusing on its dividend and stock split history. It notes that no dividend data is available, indicating that the company has not distributed dividends in the past five years. Key financial metrics such as …

ICU Medical, Inc. Revenue Breakdown – TRADEGATE:IC7

ICU Medical, Inc. (TRADEGATE:IC7) generated 1.88 billion EUR in revenue last year, with its Consumables segment being the top performer, contributing 944.33 million EUR. The United States was the largest geographical contributor, accounting for 1.15 billion EUR of the company's revenue. The article provides …

Icu Medical (ICUI) Q1 2024 Earnings Report - Results, Call & Slides

ICU Medical (ICUI) reported its Q1 2024 earnings, beating analyst expectations with an actual EPS of $0.96 against a consensus of $0.82 and revenue of $565.96 million compared to an expected $552.25 million. Despite beating estimates, the company's EPS saw a year-over-year decrease from …

ICU Medical schedules Q2 2026 earnings call for August 6

ICU Medical Inc. (NASDAQ: ICUI) has announced that its second-quarter 2026 earnings will be released on Thursday, August 6, 2026, at approximately 4:00 p.m. ET. A conference call to discuss these results will follow at 4:30 p.m. ET. Investors can access the call via …

ICU Medical Announces Time of Second Quarter 2026 Earnings Conference Call

ICU Medical, Inc. (Nasdaq: ICUI) announced the schedule for its second quarter 2026 earnings release and conference call. The company will release its results on Thursday, August 6, 2026, at approximately 4:00 p.m. ET, with the conference call to follow at 4:30 p.m. ET. …

ICU Medical Sets Aug. 6 Date for Second-Quarter Results

ICU Medical (Nasdaq: ICUI) announced its second-quarter 2026 financial results will be released on Thursday, August 6, 2026, at approximately 4:00 p.m. ET. This will be followed by an earnings conference call at 4:30 p.m. ET, accessible via phone and webcast. Historically, similar announcements …

KeyBanc raises ICU Medical stock price target on pump growth By Investing.com

KeyBanc has increased its price target for ICU Medical (NASDAQ:ICUI) stock to $182 from $164, maintaining an Overweight rating due to expected steady hospital volumes and increased contributions from new infusion pump placements. The company is projected to achieve mid-single-digit organic growth from 2024 …

Responsive Playbooks and the ICUI Inflection

This article analyzes Icu Medical Inc. (NASDAQ: ICUI) using AI models to suggest three trading strategies: Position Trading, Momentum Breakout, and Risk Hedging. It highlights a strong near and mid-term sentiment for ICUI and identifies key support, resistance, and risk-reward levels. The analysis, published …

ICU Medical stock hits 52-week high at 162.53 USD

ICU Medical Inc. (ICUI) stock reached a new 52-week high of $162.18, reflecting a significant 27.93% increase over the past year. InvestingPro analysis suggests the stock is currently undervalued, with a PEG ratio of 0.57, highlighting strong investor confidence and growth potential. Recent corporate …

ICU Medical (ICUI): Buy, Sell, or Hold Post Q1 Earnings?